Angela Hamblin
Oxford University Hospitals NHS Trust(GB)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Cancer Genomics and Diagnostics, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Genomics and Rare Diseases
Most-Cited Works
- → Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli(2020)1,086 cited
- → The 100 000 Genomes Project: bringing whole genome sequencing to the NHS(2018)466 cited
- → Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing(2019)306 cited
- → Substitution mutational signatures in whole-genome–sequenced cancers in the UK population(2022)273 cited
- → Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations(2018)242 cited
- → The immunodeficiency of chronic lymphocytic leukaemia(2008)186 cited
- → A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage(2021)165 cited
- → Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide(2017)165 cited
- → Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme(2024)157 cited
- → Essential Role of Caveolae in Interleukin-6- and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma Cells(2003)144 cited